Qiagen得到林业发展局批准进行新的测试,以迅速查明常见的胃虫病原因。 Qiagen gets FDA approval for a new test to quickly identify common causes of stomach bugs.

Qiagen是一家设在荷兰的公司,已经获得林业发展局的许可,可以进行新的胃肠病测试,即QIASTAT-Dx胃肠小组2 Mini B&V,其中确定了胃肠问题的五种常见原因,包括沙门氏菌和诺罗病毒。 Qiagen, a Netherlands-based company, has received FDA clearance for its new gastrointestinal illness test, the QIAstat-Dx Gastrointestinal Panel 2 Mini B&V, which identifies five common causes of gastrointestinal issues, including salmonella and norovirus. 这项测试的目的是全年加强病人的治疗选择,特别是在门诊环境中。 This test aims to enhance patient treatment options year-round, particularly in outpatient settings. 该公司计划很快提交第二个针对常见细菌病原体的小组。 The company plans to submit a second panel targeting common bacterial pathogens soon.